Related Experiment Video
Updated: Jul 16, 2026
09:33
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Aristolochic acids in Aristolochia chilensis
A Urzúa1, G Salgado, B K Cassels
1Department of Chemistry, Faculty of Science, University of Santiago, Chile.
Planta Medica
|May 1, 1982
Summary
This study identifies aristolochic acids I and Ia as key compounds in Aristolochia chilensis. Aristolochic acid Ia was newly isolated from this plant source, with its proton magnetic resonance spectrum analyzed.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Medicinal Botany
Background:
- Aristolochia chilensis Miers is a plant species with potential medicinal applications.
- The acid fraction of plants is often rich in bioactive compounds.
- Previous research has identified various aristolochic acids in other Aristolochia species.
Purpose of the Study:
- To identify the major acid components in the leaves and tender stems of Aristolochia chilensis.
- To report the first isolation of aristolochic acid Ia from this plant material.
- To characterize aristolochic acid Ia using its proton magnetic resonance (PMR) spectrum.
Main Methods:
- Extraction of the acid fraction from Aristolochia chilensis leaves and stems.
- Isolation of major acidic components using chromatographic techniques.
- Structure elucidation and characterization using PMR spectroscopy.
Main Results:
- Aristolochic acids I and Ia were identified as the principal components of the acid fraction.
- Aristolochic acid Ia was successfully isolated from Aristolochia chilensis for the first time.
- The PMR spectrum of the isolated aristolochic acid Ia was recorded and analyzed.
Conclusions:
- Aristolochia chilensis contains significant amounts of aristolochic acids I and Ia.
- The isolation and characterization of aristolochic acid Ia contribute to the phytochemical understanding of this species.
- Further research may explore the biological activities of these isolated compounds.
Related Concept Videos
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...